Note:

The Company has elected to provide non-GAAP financial results that exclude the items below as this presentation is common among companies that are active acquirors and whose results are, accordingly, affected by such charges, because this information is used by management to evaluate operating results and because it believes this information will assist investors in making period to period comparisons of the Company's operating results.
(a)   Goodwill impairment charged
(b) Amortization expense associated with acquired intangible assets with definite lives.
(c) Trade name impairment charge associated with acquired trade names.
(d) Restructuring charge consisting of accruals for employee severance costs and associated exit and disposal costs.
(e) Direct costs of acquisitions that are expensed pursuant to the requirement of ASC 805.
(f) Fair value adjustment of inventory associated with the acquisitions of Embla and Nicolet included as a component of cost of sales in accordance with ASC 805.
(g) Fair value adjustment of backlog associated with the acquisition of Nicolet included as a component of marketing and selling costs in accordance with ASC 805.
(h) Acceleration of depreciation of pre-existing ERP systems associated with the implementation of the North American phase of a world-wide enterprise resource planning platform.

If you liked this article you might like

Natus Medical (BABY) Stock Surges on Q3 Results, Guidance

Natus Medical (BABY) Stock Drops on Downbeat Q3 Forecast

Natus Medical (BABY) Is Today's Dead Cat Bounce Stock

Natus Medical (BABY) Stock Plunges on Preliminary Q1 Revenue

Today's Strong And Under The Radar Stock: Natus Medical (BABY)